High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle

Molecular Therapy

Volumn 2, Issue 3, 2000, Pages 204-210

  Bettan, Mickaël ^a   Emmanuel, Florence ^a   Darteil, Raphaël ^b   Caillaud, Jean Michel ^a   Soubrier, Fabienne ^a   Delaere, Pia ^a   Branelec, Didier ^a   Mahfoudi, Abderrahim ^a   Duverger, Nicolas ^a   Scherman, Daniel ^a  

^a SANOFI   (France)

^b Aventis Gencell   (United States)

Author keywords

Blood; Circulation; Electric pulse mediated gene transfer; Electrotransfer; Gene therapy; Gene transfer; Human Factor IX; Secreted human placental alkaline phosphatase; Skeletal muscle

Indexed keywords

ALKALINE PHOSPHATASE; BLOOD CLOTTING FACTOR 9;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; ELECTROPORATION; ENZYMOLOGY; FEMALE; GENE TRANSFER; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NUDE MOUSE; SECRETION; SKELETAL MUSCLE;

ALKALINE PHOSPHATASE; ANIMALS; ELECTROPORATION; FACTOR IX; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; MUSCLE, SKELETAL;

EID: 0034269179     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0117     Document Type: Article

References (22)

1. Kay, M. A., et al. (1994). In vivo hepatic gene therapy: Complete albeit transient correction of Factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91: 2353-2357.
2. Connelly, S., et al. (1998). Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91: 3273-3281.
3. Al-Hendy, A., Hortelano, G., Tannenbaum, G. S., and Chang, P. L. (1995). Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts. An alternate approach to somatic gene therapy. Hum. Gene Ther. 6: 165-175.
4. Naffakh, N., et al. (1996). Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum. Gene Ther. 7: 11-21.
5. Herzog, R., et al. (1997). Stable gene transfer and expression of human blood coagulation Factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94: 5804-5809.
6. Simionescu, N., and Simionescu, M. (1988). Endothelial Cell Biology in Health and Disease. Plenum Press, New York.
7. Aihara, H., and Miyazaki, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16: 867-870.
8. Mir, L., Bureau, M., Rangara, R., Schwartz, B., and Scherman, D. (1998). Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C. R. Acad. Sci. Sci. Vie/Life Sci. 321: 893-899.
9. Mir, L., et al. (1999). High efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96: 4262-4267.
10. Rizzuto, G., et al. (1999). Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. USA 96: 6417-6422.
11. Vicat, J. M., et al. (2000). Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum. Gene Ther. 11: 909-916.
12. Kreiss, P., Bettan, M., Crouzet, J., and Scherman, D. (1999). Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J. Gene Med. 1: 245-250.
13. Bettan, M., Darteil, R., and Scherman, D. (1999). Secreted human placental alkaline phosphatase as a reporter for in vivo gene transfer. Anal. Biochem. 271: 187-189.
14. Soubrier, F. B. C., et al. (1999). pCOR: A new design of plasmid vectors for nonviral gene therapy. Gene Ther. 6: 1482-1488.
15. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning, Vol. 1, 2nd ed. Cold Spring Harbor Laboratory Press, New York.
16. Wolff, J. A., et al. (1990). Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
17. Kay, M. A. (2000). Evidence for gene transfer and expression of Factor IX in haemophilia B patients treated with AAV vector. Nat. Genet. 24: 257-261.
18. Heartlein, M. W., et al. (1994). Long-term production and delivery of human growth hormone in vivo. Proc. Natl. Acad. Sci. USA 91: 10967-10971.
19. Yao, S., Wilson, J. M., Nabel, E. G., Kurachi, S., Hachiya, H. L., and Kurachi, K. (1991). Expression of human Factor IX in rat capillary endothelial cells: Toward somatic gene therapy for hemophilia B. Proc. Natl. Acad. Sci. USA 88: 8101-8105.
20. Thompson, A. R. (1995). Progress toward gene therapy for the haemophilias. Thromb. Haemost. 74: 45-51.
21. Kaufman, R. (1999). Advances toward gene therapy for hemophilia at the millennium. Hum. Gene Ther. 10: 2091-2107.
22. Keith, J., et al. (1995). Evaluation of recombinant human Factor IX: Pharmacokinetic studies in the rat and the dog. Thromb. Haemost. 73: 101-105.